Pantoprazol Reiwa Healthcare (Pantoprazole)

Pantoprazole is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions:

• Gastro‑oesophageal reflux disease (GERD): improves symptoms and promotes healing of the oesophageal lining.
• Erosive esophagitis: heals erosions and reduces further damage.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion.
• Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

• Pantoprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding covalently to the pump’s cysteine residues, it blocks the final step of acid production, leading to a sustained reduction in gastric acidity throughout the dosing interval.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache
• Diarrhea
• Nausea
• Abdominal pain
• Flatulence
• Constipation

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis)
• Clostridioides difficile‑associated colitis
• Low magnesium levels (hypomagnesemia)
• Acute interstitial nephritis
• Fracture risk with long‑term use
• Vitamin B12 deficiency with prolonged therapy.

When prescribing Pantoprazole, consider the following precautions:

• Assess renal function: dose adjustment may be required in severe renal impairment.
• Monitor magnesium levels: prolonged therapy can lead to hypomagnesemia.
• Evaluate bone health: long‑term use may be associated with increased fracture risk.
• Review concomitant medications: potential for drug‑drug interactions.
• Pregnancy and lactation: use only if clearly needed.
• Store at below 25°C: keep in the original packaging, protect from moisture.

Pantoprazole may interact with several medicines. Monitor patients carefully.

Major Interactions (​Avoid)

• Ketamine ( ​  )  

-   -  t ewline Moderate Interactions (​Monitor Closely): -  t . - . t """"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""